Uricalm Tablet, Film Coated
Product Images NDC 52389-241

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Uricalm (NDC 52389-241). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kobayashi Healthcare International, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Uricalm24a7rc

Uricalm24a7rc
This is information regarding a medication called Phenazopyridine Hydrochloride 99.5mg, which provides temporary relief of pain during urination, burning sensation or urgency caused by urinary tract infections. The product should not be used if the patient has liver or kidney issues, allergies to food, preservatives or dyes, or has had hypersensitive reactions to Phenazopyridine Hydrochloride. This product may cause stomach upset and a reddish-orange discoloration of urine, but they are non-harmful temporary effects. Adults can swallow two tablets with water after meals, up to three times daily for a maximum of 2-days. Do not exceed the recommended dosage of 12 tablets in two days. The medication is produced under the trade name Uricalm, and it contains cranberry powder, which is used to maintain urinary tract health. The package includes 24 tablets, and the product should be kept away from the reach of children. The text also contains some warnings and precautions associated with the use of this medication.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.